Summit Therapeutics co-CEO spouse exercises 500K-share option
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Summit Therapeutics Inc. (SMMT) Co-Chief Executive Officer Robert W. Duggan reported that his spouse exercised an option for 500,000 common shares on November 16, 2026, at an exercise price of $1.06 per share. Afterward, the spouse held 531,000 common shares indirectly and 800,000 options. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) F1, F3 | 500,000 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 500,000 | $1.06 | $530K |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock F2 | -- | -- | -- |
| Holding | Common Stock F2 | -- | -- | -- |
| Holding | Common Stock F2 | -- | -- | -- |
Footnotes (3)
- F1. On November 16, 2026, the Spouse of Reporting Person exercised an option to purchase 500,000 shares of the Issuer's common stock at an exercise price of $1.06 per share.
- F2. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
- F3. The option was granted to the Spouse of Reporting Person on June 28, 2022, subject to certain performance criteria. On August 23, 2024, based on satisfaction of certain performance criteria, the option vested as to 260,000 shares. On April 29, 2025, the option was modified to require only the service-based vesting requirements to continue to be satisfied in order to become fully vested; the option vested as to 520,000 shares on April 29, 2025 and the remaining 520,000 will vest in three equal annual installments, with the first such installment having occurred on October 13, 2025.
Key Figures
Key Terms
exercise price financial
performance criteria financial
service-based vesting requirements financial
beneficial ownership regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were the vesting terms for the SMMT option?
AI-generated analysis. How Rhea-AI works. Not financial advice.